Organovo Logo     Print Page | Close Window

Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the high-value drug profiling and therapeutic tissues markets
2018 Annual Report Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) + 0.01 (0.84%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $1.20 with a 52 week high of $2.28 and a 52 week low of $0.91.
Recent Investor News
Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Organovo Reports Fiscal First-Quarter 2019 Results; Company Outlines and Expands Key Clinical Development Goals
Investor Events
There are currently no events scheduled.
Featured Reports
2018 Annual Report
2018 Proxy Statement
Latest Tweets